The mission of the Flow Cytometry Shared Resource (also known as FACS) Facility is to provide state-of-the-art highly available flow cytometry and cell-sorting services to the Stanford research community. To fulfill this mission, the Facility maintains three cell sorters and four flow analyzers in the Beckman Center in the School of Medicine. Four full-time and seven part-time staff work in the Facility, providing quality control, maintenance and operation of these instruments, as well as user training and consultation on experimental design and data analysis. The staff embodies over 125 years of flow cytometry experience, including developing some of the major advances of the field, such as compensation, cloning and large numbers of measurement parameters. The Facility Faculty Advisor is also highly experienced with flow cytometry, having used it as a research tool and helped to develop new applications over a 15-year period. The Flow Cytometry Shared Resource Facility billed 10,094 hours for instrument use in 2008. This represented 389 users from 153 different laboratories at Stanford. Cancer Center members provide the majority of this use, representing 117 of the laboratories and logging 76% of the hours. The FY 2008-2009 budget is over $900,000 and is expected to grow as new instrumentation is added. Currently, instruments with greater capabilities are utilized at close to 100% capacity. To this end, a new high-end analyzer and cell sorter have recently been obtained. The future goals of the Facility include expanding its educational program and bringing in new technologies and instrumentation, in addition to continuing to providing the highest quality flow cytometry services to the Cancer Center.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Stanford University
United States
Zip Code
Lee, Bee L; Fan, Shenghua K; Lu, Ying (2017) A curve-free Bayesian decision-theoretic design for two-agent Phase I trials. J Biopharm Stat 27:34-43
Mohanty, Suchismita; Chen, Zixin; Li, Kai et al. (2017) A Novel Theranostic Strategy for MMP-14-Expressing Glioblastomas Impacts Survival. Mol Cancer Ther 16:1909-1921
Alcántara-Hernández, Marcela; Leylek, Rebecca; Wagar, Lisa E et al. (2017) High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization. Immunity 47:1037-1050.e6
Chao, Mark P; Gentles, Andrew J; Chatterjee, Susmita et al. (2017) Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease. Cell Stem Cell 20:329-344.e7
Rogers, Zoë N; McFarland, Christopher D; Winters, Ian P et al. (2017) A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo. Nat Methods 14:737-742
Sun, Ruping; Hu, Zheng; Sottoriva, Andrea et al. (2017) Between-region genetic divergence reflects the mode and tempo of tumor evolution. Nat Genet 49:1015-1024
Jin, Yuxue; Lai, Tze Leung (2017) A new approach to regression analysis of censored competing-risks data. Lifetime Data Anal 23:605-625
Clarke, Christina A; Glaser, Sally L; Leung, Rita et al. (2017) Prevalence and characteristics of cancer patients receiving care from single vs. multiple institutions. Cancer Epidemiol 46:27-33
Han, Summer S; Ten Haaf, Kevin; Hazelton, William D et al. (2017) The impact of overdiagnosis on the selection of efficient lung cancer screening strategies. Int J Cancer 140:2436-2443
Wender, Paul A; Hardman, Clayton T; Ho, Stephen et al. (2017) Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV. Science 358:218-223

Showing the most recent 10 out of 227 publications